Multivesicular liposomes with controlled release of encapsulated biologically active substances
AssigneeSkyePharma Inc.
InventorsMantripragada Bhima Sankaram, Sinil Kim
Life of this patent
Estimating the term…
Abstract
A multivesicular liposome composition containing at least one acid other than a hydrohalic acid and at least one biologically active substance, the vesicles having defined size distribution, adjustable average size, internal chamber size and number, provides a controlled release rate of the biologically active substance from the composition. A process for making the composition features addition of a non-hydrohalic acid effective to sustain and control the rate of release of an encapsulated biologically active substance from the vesicles at therapeutic levels in vivo.
Claims35
A multivesicular liposome having multiple non-concentric chambers with internal membranes distributed as a network throughout, produced by a method comprising the steps of:
- (a) forming a water-in-oil emulsion from two immiscible components, the two immiscible components being:
- 1) a lipid component comprising at least one organic solvent, at least one amphipathic lipid, and at least one neutral lipid lacking a hydrophilic head group, and
- 2) a first aqueous component;
- said water-in-oil emulsion further comprising:
- 3) non-hydrohalic acid in a concentration range from about 0.1 mM to about 0.5 M, wherein the concentration is selected to provide controlled release of the biologically active substance in 4) from the liposome, and
- 4) at least one biologically active substance;
- said non-hydrohalic acid and said biologically active substance being independently incorporated into the lipid component, the first aqueous component, or both;
- (b) mixing the water-in-oil emulsion containing the non-hydrohalic acid with a second aqueous component to form solvent spherules;
- and thereafter
- (c) removing the organic solvent from the solvent spherules to form multivesicular liposomes.
Dependencies are inferred from the claim text.